TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotage AB
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,862,000
|
1,566,000
|
1,232,000 |
| Financial expenses |
41,000
|
14,000
|
12,000 |
| Earnings before taxes |
303,000
|
348,000
|
269,000 |
| EBITDA |
463,000
|
429,000
|
347,000 |
| Total assets |
4,931,000
|
2,339,000
|
1,992,000 |
| Current assets |
1,447,000
|
1,031,000
|
774,000 |
| Current liabilities |
701,000
|
414,000
|
310,000 |
| Equity capital |
3,657,000
|
1,637,000
|
1,371,000 |
| - share capital |
112,000
|
93,000
|
92,000 |
| Employees (average) |
674
|
517
|
497 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
74.2%
|
70.0%
|
68.8% |
| Turnover per employee |
2,763
|
3,029
|
2,479 |
| Profit as a percentage of turnover |
16.3%
|
22.2%
|
21.8% |
| Return on assets (ROA) |
7.0%
|
15.5%
|
14.1% |
| Current ratio |
206.4%
|
249.0%
|
249.7% |
| Return on equity (ROE) |
8.3%
|
21.3%
|
19.6% |
| Change turnover |
296,000
|
334,000
|
139,722 |
| Change turnover % |
19%
|
27%
|
13% |
| Chg. No. of employees |
157
|
20
|
34 |
| Chg. No. of employees % |
30%
|
4%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.